2-(Acetylamino)-2-deoxy-beta-D-galactopyranosylamine 3,4,6-Triacetate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(Acetylamino)-2-deoxy-beta-D-galactopyranosylamine 3,4,6-Triacetate
• 英文别名: (5-acetamido-3,4-diacetyloxy-6-aminooxan-2-yl)methyl acetate
• 化学式: C₁₄H₂₂N₂O₈
• 分子量: 346.33
• InChiKey: DKGKXBJJPLBTOQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  24
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  143
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• [EN] POLYNUCLEOTIDE CONSTRUCTS HAVING AN AUXILIARY MOIETY NON-BIOREVERSIBLY LINKED TO AN INTERNUCLEOSIDE PHOSPHATE OR PHOSPHOROTHIOATE<br/>[FR] CONSTRUCTIONS POLYNUCLÉOTIDIQUES COMPORTANT UNE FRACTION AUXILIAIRE LIÉE DE FAÇON NON BIORÉVERSIBLE À UN PHOSPHATE INTERNUCLÉOSIDIQUE OU À UN PHOSPHOROTHIOATE
  申请人：SOLSTICE BIOLOGICS LTD

  公开号：WO2017100461A1

  公开（公告）日：2017-06-15

  The invention features a hybridized polynucleotide construct including a passenger strand, a guide strand loadable into a RISC complex, and one or more auxiliary moieties. At least one of the auxiliary moieties is non-bioreversibly linked to an internucleoside phosphate or phosphorothioate in the passenger strand. The invention further features methods of delivery a polynucleotide construct to a cell and methods of reducing the expression of a protein in a cell. The methods typically involve contacting the cell with the hybridized polynucleotide construct.

  该发明涉及一种杂交多核苷酸构造，包括一个载体链、一个可装载到RISC复合物中的引导链，以及一个或多个辅助基团。至少一个辅助基团与载体链中的一个核苷酸间磷酸酯或磷硫酸酯非可逆地连接。该发明还涉及将多核苷酸构造递送至细胞的方法以及减少细胞中蛋白质表达的方法。这些方法通常涉及将细胞与杂交多核苷酸构造接触。
• Biosensors
  申请人：Deshong R. Philip

  公开号：US20070249063A1

  公开（公告）日：2007-10-25

  Methods for detecting a biological interaction comprising administering a substrate comprising a ligand attached to the substrate wherein the ligand binds to a receptor and wherein a signal is produced. Also disclosed is a biosensor comprising a substrate and a ligand wherein the ligand is attached to the surface of the substrate and wherein the ligand preferentially binds to a receptor.
• [EN] OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION<br/>[FR] CONJUGUÉS LIGANDS D'OLIGONUCLÉOTIDES ET PROCÉDÉ POUR LEUR PRÉPARATION
  申请人：ALNYLAM PHARMACEUTICALS INC

  公开号：WO2015006740A2

  公开（公告）日：2015-01-15

  The present invention relates to ligand conjugates of oligonucleotides (e.g., iRNA agents) and methods for their preparation. The ligands are derived primarily from monosaccharides These conjugates are useful for the in vivo delivery of oligonucleotides.
• [EN] POLYNUCLEOTIDE CONSTRUCTS HAVING BIOREVERSIBLE AND NON-BIOREVERSIBLE GROUPS<br/>[FR] CONSTRUCTIONS DE POLYNUCLÉOTIDES POSSÉDANT DES GROUPES BIORÉVERSIBLES ET NON BIORÉVERSIBLES
  申请人：SOLSTICE BIOLOG LTD

  公开号：WO2015188197A2

  公开（公告）日：2015-12-10

  The invention features a hybridized polynucleotide construct containing a passenger strand, a guide strand loadable into a RISC complex, and (i) a 3'-terminal or an internucleotide non-bioreversible group in the guide strand; or (ii) a 5'-terminal, a 3'-terminal, or an internucleotide non-bioreversible group in the passenger strand, and a 5'-terminal, a 3'-terminal, or an internucleotide disulfide bioreversible group in the guide strand or the passenger strand. The invention also features methods of delivering a polynucleotide to a cell using the hybridized polynucleotide construct. The invention further features methods of reducing the expression of a polypeptide in a cell using the hybridized polynucleotide construct.